In our group’s interrogation of the mechanism by which 4PBA acts, we identified that a non-classical ER chaperone ERp29 is upregulated in response to 4PBA treatment of CF bronchiolar epithelial cells (Suaud et al., 2011a). Here, ERP29 is linked to cystic fibrosis.